Mario Gabelli's AMGN Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 5.1K shares of Amgen Inc. (AMGN) worth $1.45 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 27.8K shares. Largest reduction occurred in Q4 2014, reducing 20.5K shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Mario Gabelli
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +17,661 | Add 0.00% | 17,660 | $98.64 |
| Q3 2013 | +4,760 | Add 26.95% | 22,420 | $111.91 |
| Q4 2013 | +1,200 | Add 5.35% | 23,620 | $114.10 |
| Q1 2014 | +8,945 | Add 37.87% | 32,565 | $123.35 |
| Q2 2014 | +27,770 | Add 85.28% | 60,335 | $118.37 |
| Q3 2014 | -385 | Reduce 0.64% | 59,950 | $140.47 |
| Q4 2014 | -20,450 | Reduce 34.11% | 39,500 | $159.29 |
| Q1 2015 | +485 | Add 1.23% | 39,985 | $159.86 |
| Q2 2015 | +590 | Add 1.48% | 40,575 | $153.52 |
| Q3 2015 | -25 | Reduce 0.06% | 40,550 | $138.32 |
| Q4 2015 | -1,375 | Reduce 3.39% | 39,175 | $162.32 |
| Q1 2016 | -1,965 | Reduce 5.02% | 37,210 | $149.93 |
| Q2 2016 | -885 | Reduce 2.38% | 36,325 | $152.15 |
| Q3 2016 | -13,900 | Reduce 38.27% | 22,425 | $166.82 |
| Q4 2016 | -405 | Reduce 1.81% | 22,020 | $146.23 |
| Q1 2017 | -996 | Reduce 4.52% | 21,024 | $164.05 |
| Q2 2017 | -57 | Reduce 0.27% | 20,967 | $172.22 |
| Q3 2017 | -9,635 | Reduce 45.95% | 11,332 | $186.46 |
| Q4 2017 | -5,991 | Reduce 52.87% | 5,341 | $173.94 |
| Q1 2018 | +65 | Add 1.22% | 5,406 | $170.55 |
| Q2 2018 | -145 | Reduce 2.68% | 5,261 | $184.57 |
| Q4 2018 | +670 | Add 12.74% | 5,931 | $194.74 |
| Q2 2019 | +113 | Add 1.91% | 6,044 | $184.32 |
| Q3 2019 | +1,242 | Add 20.55% | 7,286 | $193.52 |
| Q4 2019 | -1,070 | Reduce 14.69% | 6,216 | $240.99 |
| Q1 2020 | +70 | Add 1.13% | 6,286 | $202.67 |
| Q2 2020 | -380 | Reduce 6.05% | 5,906 | $235.86 |
| Q3 2020 | +55 | Add 0.93% | 5,961 | $254.15 |
| Q4 2020 | -1,450 | Reduce 24.32% | 4,511 | $229.88 |
| Q1 2021 | +1,713 | Add 37.97% | 6,224 | $248.88 |
| Q2 2021 | +70 | Add 1.12% | 6,294 | $243.72 |
| Q3 2021 | -1,950 | Reduce 30.98% | 4,344 | $212.71 |
| Q4 2021 | +85 | Add 1.96% | 4,429 | $224.88 |
| Q1 2022 | +1,867 | Add 42.15% | 6,296 | $241.74 |
| Q2 2022 | -755 | Reduce 11.99% | 5,541 | $243.28 |
| Q3 2022 | -458 | Reduce 8.27% | 5,083 | $225.46 |
| Q4 2022 | +15 | Add 0.30% | 5,098 | $262.64 |
| Q1 2023 | +470 | Add 9.22% | 5,568 | $241.75 |
| Q2 2023 | +128 | Add 2.30% | 5,696 | $222.02 |
| Q3 2023 | -455 | Reduce 7.99% | 5,241 | $268.76 |
| Q4 2023 | -81 | Reduce 1.55% | 5,160 | $288.02 |
| Q1 2024 | +271 | Add 5.25% | 5,431 | $284.32 |
| Q2 2024 | +164 | Add 3.02% | 5,595 | $312.45 |
| Q3 2024 | -344 | Reduce 6.15% | 5,251 | $322.21 |
| Q4 2024 | +30 | Add 0.57% | 5,281 | $260.64 |
| Q1 2025 | -736 | Reduce 13.94% | 4,545 | $311.55 |
| Q2 2025 | +1,140 | Add 25.08% | 5,685 | $279.21 |
| Q3 2025 | -545 | Reduce 9.59% | 5,140 | $282.20 |
Mario Gabelli's Amgen Investment FAQs
Mario Gabelli first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 17,660 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Amgen Inc. (AMGN) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's largest addition to Amgen Inc. (AMGN) was in Q2 2014, adding 60,335 shares worth $7.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 5,140 shares of Amgen Inc. (AMGN), valued at approximately $1.45 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.01% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's peak holding in Amgen Inc. (AMGN) was 60,335 shares, as reported at the end of Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.